| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $96K | +136.1% |
| Cost of Revenue | $7K | +194.3% |
| Gross Profit | $88K | +132.2% |
| R&D Expense | $16.8M | +5.7% |
| SG&A Expense | $6.4M | +18.9% |
| Operating Income | -$23.1M | -8.8% |
| Net Income | -$22.5M | -7.1% |
| EPS (Basic) | -$0.19 | -5.6% |
| EPS (Diluted) | -$0.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.7M | -12.0% |
| Accounts Receivable | $46K | +50.0% |
| Current Assets | $28.1M | -14.0% |
| Total Assets | $37.8M | -9.5% |
| Current Liabilities | $1.8M | -30.9% |
| Total Liabilities | $4.4M | -18.1% |
| Stockholders' Equity | $33.4M | -8.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.6M | -27.1% |
| Capital Expenditures | $2.3M | -31.1% |
| Investing Cash Flow | -$2.7M | +8.8% |
| Financing Cash Flow | $14.5M | -35.7% |
| Free Cash Flow | -$17.8M | -14.7% |
| -5.6% |